Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-1989 | 12-1988 | 12-1987 | |
| Sales | 1,589,500 | 0 | 0 |
| Cost of Goods | 485,900 | N/A | N/A |
| Gross Profit | 1,103,600 | N/A | N/A |
| Operating Expenses | 698,000 | 0 | 0 |
| Operating Income | 406,500 | N/A | N/A |
| Pre-tax Income | 406,500 | 0 | 0 |
| Income Tax | 140,300 | N/A | N/A |
| Net Income Continuous | 266,200 | N/A | N/A |
| Net Income | $266,200 | $N/A | $N/A |
| EPS Basic Total Ops | 0.23 | N/A | N/A |
| EPS Basic Continuous Ops | 0.23 | N/A | N/A |
| EPS Diluted Total Ops | 0.23 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.23 | N/A | N/A |
| EBITDA(a) | $406,500 | $N/A | $N/A |